Icon PLC (ICLR) (Q3 2026) Earnings Call Highlights: Record

Icon PLC (ICLR) reported Q3 2026 revenue of $2B, down 2.9% YoY. Direct fee revenue growth remains modest, and cancellations are slightly above average. Gross margin improved 90 bps sequentially, and adjusted EBITDA margin rose to 16.6%. The company expects Q4 SG&A expenses to increase and faces ongoing pricing pressure. Management anticipates mid-single-digit revenue growth and higher single-digit earnings growth in 2027, with formal guidance to be provided in Q4.

Original reporting
Published Oct 28, 2026, 11:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Icon PLC (ICLR) (Q3 2026) Earnings Call Highlights: Record — source image
Decision brief

The 30-second read

$ICLRBullishMed
01

Why it matters

The earnings miss and lack of forward guidance create downside risk for the stock.

02

Market read

First‑time disclosure of Q3 results; investors will reassess earnings outlook and valuation.

03

What to watch

Strong book‑to‑bill of 1.3x suggests pipeline strength despite near‑term revenue dip.

Relevance 7/10Novelty 8/10Timing: after-hours earnings release

Background

Icon PLC reported Q3 2026 results, highlighting a 2.9% revenue decline, modest fee growth, and margin pressure.

Company-level read

Ticker impact

$ICLRBullishHigh confidence
Context

Q3 earnings show revenue down 2.9% YoY, modest fee growth and margin pressure, with no 2027 guidance yet.

Expected impact

likely downside as investors digest revenue decline and guidance uncertainty

Evidence & confidence

The disclosed numbers are new and materially below expectations, creating immediate pricing pressure.

Market effects

Signals slower growth for the CRO sector and may affect peers with similar fee structures.

UK‑listed CROs could see modest pressure.

Limited to healthcare services investors; no broad market effect.

Counterpoint

If the pass‑through component accelerates, margin recovery could be faster than implied.

Key entities

  • Icon PLC

    UK‑based contract research organization.

Related articles

$ICLRHighAI 8/10

ICLR Stock Jumps As Guidance And Backlog Impress Wall Street

ICON plc (NASDAQ: ICLR) stock rose 16.39% on October 28, 2026, after beating Q3 earnings expectations and raising 2026 revenue guidance to $8.10B–$8.20B. The company reported adjusted EPS of $2.66 and revenue of $2.02B, with a record backlog and $400M in share repurchases. Analysts have mixed reactions, with upgrades from Bank of America and RBC, while UBS remains cautious.

$ICLRHighAI 8/10

ICLR Stock Jumps As Earnings Beat And Guidance Rise

ICON plc (ICLR) stock rose 11.54% after Q3 earnings beat expectations, with revenue of $2.02B and EPS of $2.66. The company raised full-year guidance, citing strong demand and a record backlog. Analysts have mixed views, with some upgrading and others warning of risks. ICLR trades at a premium multiple, with technical indicators showing strong momentum.

$ICLRHighAI 8/10

Icon PLC: Q3 Earnings Snapshot

Icon PLC reported Q3 net income of $122.1M, or $1.58 per share, and adjusted earnings of $2.66 per share, exceeding analyst expectations of $2.64 per share. Revenue was $2.02B. The company forecasted full-year earnings of $10.35-$10.65 per share and revenue of $8.1B-$8.2B.